Bridgeway Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$159K	Buy	+18,000	New	+$159K	﹤0.01%	1006